E-ISSN 2063-5346
 

Research Article 


SYNTHESIS, INVESTIGATION AND ANTICANCER EVALUATION OF NOVEL MACROCYCLIC FORMAZAN AND LINEAR FORMAZAN

Sarah Mohammed Abed, Nagham Mahmood Aljamali.

Abstract
Innovative Macrocyclic Formazan Compounds as a bio-compounds were generated and advanced globally designed for the initial stage by investigator Professor. Dr. Nagham M. Aljamali in 2019) via more than five steps of reaction with various catalyst like (Sodium- alkali 5% ,Pipridine, trimethyl amine , etc.). For that reason, these invented compounds act one of the advanced and new assemblies which have a deficiency of references and researches which lead us to prepare and create a restraint of these innovated compounds and studied by abundant requests in future literatures represented by biological, pharmaceutical, nano, antimicrobial studies, also as anticancer agents ,Normal Formazan was first synthesis over a century ago, but still attention of chemists ,biologists ,technologists and other specialists and here in this research. A numeral of applied spectroscopic studies have been used to revel their chemical assemblies which delivered to sturdy indications of their chemical assemblies through various technical devices like (FT IR-Ranges, 1H.NMR-Ranges, 13C.NMR-Ranges)., Also anticancer study

Key words: Macrocyclic Formazan, Normal Formazan ,Schiff base, Azo, Anil, innovative compounds, breast cancer.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Sarah Mohammed Abed
Articles by Nagham Mahmood Aljamali
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Abed SM, Aljamali NM. SYNTHESIS, INVESTIGATION AND ANTICANCER EVALUATION OF NOVEL MACROCYCLIC FORMAZAN AND LINEAR FORMAZAN. ECB. 2022; 11(11): 46-63. doi:10.31838/ecb/2022.11.11.006


Web Style

Abed SM, Aljamali NM. SYNTHESIS, INVESTIGATION AND ANTICANCER EVALUATION OF NOVEL MACROCYCLIC FORMAZAN AND LINEAR FORMAZAN. https://www.eurchembull.com/?mno=131725 [Access: January 21, 2023]. doi:10.31838/ecb/2022.11.11.006


AMA (American Medical Association) Style

Abed SM, Aljamali NM. SYNTHESIS, INVESTIGATION AND ANTICANCER EVALUATION OF NOVEL MACROCYCLIC FORMAZAN AND LINEAR FORMAZAN. ECB. 2022; 11(11): 46-63. doi:10.31838/ecb/2022.11.11.006



Vancouver/ICMJE Style

Abed SM, Aljamali NM. SYNTHESIS, INVESTIGATION AND ANTICANCER EVALUATION OF NOVEL MACROCYCLIC FORMAZAN AND LINEAR FORMAZAN. ECB. (2022), [cited January 21, 2023]; 11(11): 46-63. doi:10.31838/ecb/2022.11.11.006



Harvard Style

Abed, S. M. & Aljamali, . N. M. (2022) SYNTHESIS, INVESTIGATION AND ANTICANCER EVALUATION OF NOVEL MACROCYCLIC FORMAZAN AND LINEAR FORMAZAN. ECB, 11 (11), 46-63. doi:10.31838/ecb/2022.11.11.006



Turabian Style

Abed, Sarah Mohammed, and Nagham Mahmood Aljamali. 2022. SYNTHESIS, INVESTIGATION AND ANTICANCER EVALUATION OF NOVEL MACROCYCLIC FORMAZAN AND LINEAR FORMAZAN. European Chemical Bulletin, 11 (11), 46-63. doi:10.31838/ecb/2022.11.11.006



Chicago Style

Abed, Sarah Mohammed, and Nagham Mahmood Aljamali. "SYNTHESIS, INVESTIGATION AND ANTICANCER EVALUATION OF NOVEL MACROCYCLIC FORMAZAN AND LINEAR FORMAZAN." European Chemical Bulletin 11 (2022), 46-63. doi:10.31838/ecb/2022.11.11.006



MLA (The Modern Language Association) Style

Abed, Sarah Mohammed, and Nagham Mahmood Aljamali. "SYNTHESIS, INVESTIGATION AND ANTICANCER EVALUATION OF NOVEL MACROCYCLIC FORMAZAN AND LINEAR FORMAZAN." European Chemical Bulletin 11.11 (2022), 46-63. Print. doi:10.31838/ecb/2022.11.11.006



APA (American Psychological Association) Style

Abed, S. M. & Aljamali, . N. M. (2022) SYNTHESIS, INVESTIGATION AND ANTICANCER EVALUATION OF NOVEL MACROCYCLIC FORMAZAN AND LINEAR FORMAZAN. European Chemical Bulletin, 11 (11), 46-63. doi:10.31838/ecb/2022.11.11.006